The effect of elagolix on bone mineral density: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain

In: Fertility and Sterility · 2016 · vol. 106(3) , pp. e276–e277 · doi:10.1016/j.fertnstert.2016.07.794 · W4237408053
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-07

This study evaluated elagolix's impact on bone mineral density in women with endometriosis-associated pain, reporting safety outcomes from two placebo-controlled trials.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK